2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2014 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2020 | 0 | 5.807.026 | 820.589 | 2 | ||
2014 | 0 | 5.999.991 | 184.863 | 1 |
Total number of partners: 26
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 26
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2020-04-01 | Rapid therapy development through Open nCoronavirus Vaccine Platform | OPENCORONA | participant | 3.000.000 | 7 |
2020-04-01 | FIGHTING-OFF CORONAVIRUS (SARS-CoV-2) WITH BROAD-SPECTRUM ANTIVIRALS: ESTABLISHING ANIMAL VIRAL CHALLENGE MODEL | Fight-nCoV | participant | 2.807.026 | 6 |
2014-02-01 | Anti-Parasitic Drug Discovery in Epigenetics | A-PARADDISE | participant | 5.999.991 | 16 |